Bryn Mawr Capital Management Inc’s ResMed RMD Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,271	Closed	-$625K	–	240
2015 Q3	$625K	Buy	+12,271	New	+$660K	0.11%	190
2015 Q2	–	Sell	-3,336	Closed	-$239K	–	543
2015 Q1	$239K	Sell	3,336 -2,209	-40%	-$143K	0.03%	416
2014 Q4	$311K	Buy	+5,545	New	+$290K	0.04%	372
2014 Q2	–	Sell	-13,560	Closed	-$606K	–	665
2014 Q1	$606K	Buy	13,560 +180	+1%	+$8.09K	0.05%	284
2013 Q4	$630K	Buy	13,380 +5,160	+63%	+$261K	0.04%	269
2013 Q3	$434K	Buy	8,220 +260	+3%	+$12.6K	0.03%	353
2013 Q2	$359K	Buy	+7,960	New	+$378K	0.02%	301

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bryn Mawr Capital Management Inc's RMD Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of ResMed (RMD) in Q4 2015, closing a stake of 12,271 shares — an estimated $625K sold.

Bryn Mawr Capital Management Inc first reported a position in RMD in Q2 2013 and held it in 7 quarters. The position peaked at $630K in Q4 2013. 351 funds tracked by Wall St. Rank hold RMD as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining ResMed position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 12,271 ResMed shares in Q4 2015, an estimated $625K.
Bryn Mawr Capital Management Inc first reported a position in ResMed in Q2 2013 and held it in 7 quarters.
Bryn Mawr Capital Management Inc's ResMed position peaked at $630K in Q4 2013.
351 funds tracked by Wall St. Rank held ResMed as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.